MedPath

Ischemic Strokes While on NOAC - How Compliance Matters

Recruiting
Conditions
Stroke, Acute
Ischemic Stroke
Stroke, Cardiovascular
Atherosclerosis
Stroke, Ischemic
Stroke Syndrome
Registration Number
NCT04607070
Lead Sponsor
Chinese University of Hong Kong
Brief Summary

This study is aimed to depict the epidemiological trend, aetiologies, clinical characteristics, treatment options of IS-NOAC in face of the rapidly increasing NOAC usage. Knowledge on this ischaemic stroke entity will define clinical characteristics, identify preventable causes and inform resource allocation on the evaluation modalities, reperfusion strategies and forecast future burden of IS-NOAC.

Detailed Description

Data will be retrieved from the stroke registry of Prince of Wales Hospital which recorded all in- and out-patients with stroke or transient ischaemic attack (TIA). All consecutive adult patients with known AF who developed ischaemic stroke or TIA in 2010, 2012, 2014, 2016 and 2018 (i.e. 5 full yearly time-points) and categorize the patients according to their anticoagulation status (elaborated below) with the inclusion and exclusion criteria stated will be recruited.

All demographic data, blood results, imaging and assessment data will be retrieved from electronic patient record (CMS system) and stroke registry. All-cause mortality at 1 year will be verified via CMS system too.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
870
Inclusion Criteria
  1. Patients who were ethnic Chinese
  2. Patients with known AF
  3. Patient who suffered from ischaemic stroke
Exclusion Criteria
  1. Patient who are non-ethnic Chinese
  2. Patient who suffered from haemorrhagic stroke

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Compliance affects the outcomes of ischemic stroke during NOAC usage.30 Sept 2021

To depict epidemiological trend and aetiologies on different dosage of NOAC in stroke patients.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Chinese University of Hong Kong

🇭🇰

Hong Kong, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath